Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to clinical outcomes

View ORCID ProfileGemma Modinos, Anja Richter, Alice Egerton, Ilaria Bonoldi, Matilda Azis, Mathilde Antoniades, Matthijs Bossong, Nicolas Crossley, Jesus Perez, James M. Stone, Mattia Veronese, Fernando Zelaya, Anthony A Grace, Oliver D Howes, Paul Allen, Philip McGuire
doi: https://doi.org/10.1101/2020.12.08.20245902
Gemma Modinos
1Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
2Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
3MRC Centre for Neurodevelopmental Disorders, King’s College London, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gemma Modinos
  • For correspondence: gemma.modinos@kcl.ac.uk
Anja Richter
1Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alice Egerton
1Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ilaria Bonoldi
1Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matilda Azis
4Department of Psychology, Northwestern University, Chicago, IL, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mathilde Antoniades
5Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthijs Bossong
6Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Centre Utrecht, Utrecht, The Netherlands
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas Crossley
7Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jesus Perez
8CAMEO Early Intervention in Psychosis Service, Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK
9Department of Psychiatry, University of Cambridge, Cambridge, UK
10Department of Neuroscience, Instituto de Investigación Biomédica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James M. Stone
2Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
1Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
13South London and Maudsley Foundation NHS Trust, Maudsley Hospital, London, UK
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mattia Veronese
2Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fernando Zelaya
2Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony A Grace
11Departments of Neuroscience, Psychiatry and Psychology, University of Pittsburgh, Pittsburgh PA, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliver D Howes
1Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
3MRC Centre for Neurodevelopmental Disorders, King’s College London, UK
12MRC London Institute of Medical Sciences, Imperial College London, Hammersmith Hospital, London, UK
13South London and Maudsley Foundation NHS Trust, Maudsley Hospital, London, UK
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Allen
1Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
14Department of Psychology, University of Roehampton, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip McGuire
1Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
3MRC Centre for Neurodevelopmental Disorders, King’s College London, UK
13South London and Maudsley Foundation NHS Trust, Maudsley Hospital, London, UK
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Preclinical models propose that the onset of psychosis involves increased hippocampal activity which drives subcortical dopaminergic dysfunction. We used multi-modal neuroimaging to examine the relationship between hippocampal regional cerebral blood flow (rCBF) and striatal dopamine synthesis capacity in people at clinical high risk (CHR) for psychosis, and investigated its association with subsequent clinical outcomes.

Methods Ninety-five participants (67 CHR and 28 healthy controls) underwent pseudo-continuous arterial spin labelling and 18F-DOPA PET imaging at baseline. Clinical outcomes in CHR participants were determined after a median of 15 months follow-up, using the Comprehensive Assessment of At Risk Mental States (CAARMS) and the Global Assessment of Function (GAF) scale.

Results CHR participants with a poor functional outcome (follow-up GAF<65, n=25) showed higher rCBF in the right hippocampus compared to CHRs with a good functional outcome (GAF≥65, n=25) (familywise error [FWE] p=0·026). The relationship between right hippocampal rCBF and striatal dopamine synthesis capacity was also significantly different between groups (pFWE=0·035); the association was negative in CHR with poor outcomes (pFWE=0·012), but non-significant in CHR with good outcomes. The correlation between rCBF in this right hippocampal region and striatal dopamine function also predicted a longitudinal increase in the severity of positive psychotic symptoms (p=0·041). The relationship between hippocampal rCBF and striatal dopamine did not differ in the total CHR group relative to controls.

Interpretation These findings indicate that altered interactions between the hippocampus and the subcortical dopamine system are implicated in the pathophysiology of psychosis-related outcomes.

Competing Interest Statement

Dr. Grace receives consulting fees from Johnson & Johnson, Lundbeck, Pfizer, GSK, Merck, Takeda, Dainippon Sumitomo, Otsuka, Lilly, Roche, Asubio, and Abbott; and receives research funding from Lundbeck, Lilly, Autifony, Alkermes and Johnson & Johnson. Dr Howes has received investigator initiated research funding from and/or participated in advisory/speaker meetings organized by Astra-Zeneca, Autifony, BMS, Eli Lilly, Heptares, Invicro, Jansenn, Lundbeck, Lyden-Delta, Otsuka, Servier, Sunovion, Rand and Roche. Neither Dr Howes or his family have been employed by or have holdings/a financial stake in any biomedical company. The other authors declare no competing financial interests.

Funding Statement

This work was supported by a Wellcome Trust Programme Grant to PM, PA, ODH, JS & AAG (grant number 091667, 2011), and an MRC Research Grant to PM (grant number G0700995). GM is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (grant number 202397/Z/16/Z).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical approval was obtained from the National Health Service UK Research Ethics Committee, and all participants provided written informed consent to participate.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

We are unable to share data because participants did not provide consent for data sharing.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted December 11, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to clinical outcomes
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to clinical outcomes
Gemma Modinos, Anja Richter, Alice Egerton, Ilaria Bonoldi, Matilda Azis, Mathilde Antoniades, Matthijs Bossong, Nicolas Crossley, Jesus Perez, James M. Stone, Mattia Veronese, Fernando Zelaya, Anthony A Grace, Oliver D Howes, Paul Allen, Philip McGuire
medRxiv 2020.12.08.20245902; doi: https://doi.org/10.1101/2020.12.08.20245902
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to clinical outcomes
Gemma Modinos, Anja Richter, Alice Egerton, Ilaria Bonoldi, Matilda Azis, Mathilde Antoniades, Matthijs Bossong, Nicolas Crossley, Jesus Perez, James M. Stone, Mattia Veronese, Fernando Zelaya, Anthony A Grace, Oliver D Howes, Paul Allen, Philip McGuire
medRxiv 2020.12.08.20245902; doi: https://doi.org/10.1101/2020.12.08.20245902

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Psychiatry and Clinical Psychology
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (556)
  • Anesthesia (135)
  • Cardiovascular Medicine (1766)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (315)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10809)
  • Forensic Medicine (8)
  • Gastroenterology (594)
  • Genetic and Genomic Medicine (2959)
  • Geriatric Medicine (288)
  • Health Economics (534)
  • Health Informatics (1932)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (293)
  • HIV/AIDS (633)
  • Infectious Diseases (except HIV/AIDS) (12524)
  • Intensive Care and Critical Care Medicine (696)
  • Medical Education (300)
  • Medical Ethics (87)
  • Nephrology (324)
  • Neurology (2806)
  • Nursing (152)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1473)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (257)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (381)
  • Pediatrics (868)
  • Pharmacology and Therapeutics (367)
  • Primary Care Research (338)
  • Psychiatry and Clinical Psychology (2646)
  • Public and Global Health (5383)
  • Radiology and Imaging (1015)
  • Rehabilitation Medicine and Physical Therapy (597)
  • Respiratory Medicine (727)
  • Rheumatology (330)
  • Sexual and Reproductive Health (290)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (48)
  • Transplantation (150)
  • Urology (126)